Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate
- PMID: 25025002
- PMCID: PMC4075270
- DOI: 10.11005/jbm.2014.21.2.155
Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate
Abstract
Bisphosphonate, a potent anti-resorptive agent, is generally accepted as a safe, effective, well tolerated treatment for postmenopausal osteoporosis. Atypical femoral fracture (AFF) and bisphosphonate related osteonecrosis of jaw (BRONJ) are the increasing morbidities in patients treated with long term bisphosphonate. Pathogenic mechanisms of AFF and BRONJ are not fully identified and not identical. We report a case of BRONJ followed by AFF and its nonunion in a 67-year-old woman patient receiving an oral bisphosphonate during 7 years for the treatment of osteoporosis.
Keywords: Atypical femoral fracture; Bisphosphonate.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures




Similar articles
-
Oral Bisphosphonate Induced Recurrent Osteonecrosis of Jaw with Atypical Femoral Fracture and Subsequent Mandible Fracture in the Same Patient: A Case Report.J Orthop Case Rep. 2018 May-Jun;8(3):85-88. doi: 10.13107/jocr.2250-0685.1124. J Orthop Case Rep. 2018. PMID: 30584526 Free PMC article.
-
Prevalence and Risk Factors of Atypical Femoral Fracture Bone Scintigraphic Feature in Patients Experiencing Bisphosphonate-Related Osteonecrosis of the Jaw.Nucl Med Mol Imaging. 2018 Aug;52(4):311-317. doi: 10.1007/s13139-018-0533-x. Epub 2018 Jul 16. Nucl Med Mol Imaging. 2018. PMID: 30100944 Free PMC article.
-
Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.J Clin Endocrinol Metab. 2013 Apr;98(4):E723-6. doi: 10.1210/jc.2012-4144. Epub 2013 Mar 7. J Clin Endocrinol Metab. 2013. PMID: 23471975
-
Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.Minerva Stomatol. 2010 Apr;59(4):181-203, 204-13. Minerva Stomatol. 2010. PMID: 20360666 Review. English, Italian.
-
Bridging the gap between osteoporosis and osteonecrosis of the jaw: preventing and treating BRONJ with MK4.Compend Contin Educ Dent. 2011 Oct;32(8):e125-31. Compend Contin Educ Dent. 2011. PMID: 23738523 Review.
Cited by
-
Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.Osteoporos Int. 2017 Mar;28(3):1145-1147. doi: 10.1007/s00198-016-3840-z. Epub 2016 Nov 20. Osteoporos Int. 2017. PMID: 27866217
-
Oral Bisphosphonate Induced Recurrent Osteonecrosis of Jaw with Atypical Femoral Fracture and Subsequent Mandible Fracture in the Same Patient: A Case Report.J Orthop Case Rep. 2018 May-Jun;8(3):85-88. doi: 10.13107/jocr.2250-0685.1124. J Orthop Case Rep. 2018. PMID: 30584526 Free PMC article.
-
Osteonecrosis of the Jaw and Concomitant Atypical Femoral Fractures with Bisphosphonates: A Comprehensive Literature Review.Cureus. 2019 Jul 9;11(7):e5113. doi: 10.7759/cureus.5113. Cureus. 2019. PMID: 31523544 Free PMC article. Review.
-
Comprehensive Study of the Risk Factors for Medication-Related Osteonecrosis of the Jaw Based on the Japanese Adverse Drug Event Report Database.Pharmaceuticals (Basel). 2020 Dec 16;13(12):467. doi: 10.3390/ph13120467. Pharmaceuticals (Basel). 2020. PMID: 33339150 Free PMC article.
-
Gaps and alternative surgical and non-surgical approaches in the bone fragility management: an updated review.Osteoporos Int. 2022 Dec;33(12):2467-2478. doi: 10.1007/s00198-022-06482-z. Epub 2022 Jul 18. Osteoporos Int. 2022. PMID: 35851407 Review.
References
-
- Allen MR, Burr DB. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know. Bone. 2011;49:56–65. - PubMed
-
- Unnanuntana A, Saleh A, Mensah KA, et al. Atypical femoral fractures: what do we know about them?: AAOS Exhibit Selection. J Bone Joint Surg Am. 2013;95:e8 1–e8 13. - PubMed
-
- Ruggiero SL, Dodson TB, Assael LA, et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg. 2009;67:2–12. - PubMed
-
- Pazianas M, Miller P, Blumentals WA, et al. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther. 2007;29:1548–1558. - PubMed
-
- Giusti A, Hamdy NA, Papapoulos SE. Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case/case series studies. Bone. 2010;47:169–180. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources